Lipid Nanoparticles
Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing
Jim Ziogas
DIANT Pharma
PAO-05-24-CL-03May 30, 2024
mRNA–LNP Manufacturing
The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-03-24-CL-08Mar 18, 2024
Lipid Nanoparticles
Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform
Antonio Costa, Ph.D.
DIANT Pharma
PAO-10-23-CL-03Nov 01, 2023
Continuous Processing
US Food and Drug Administration (FDA) Purchase the LiFT System from DIANT® Pharma INC.
DIANT Pharma
PR-M07-23-03Jul 31, 2023
Lipid Nanoparticles
Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-04-23-CL-05May 06, 2023
Lipid Nanoparticles
Lipid Nanoparticles: Transforming the Nanomedicines Market
Antonio Costa, Ph.D.
DIANT Pharma
PAO-02-23-CL-01Feb 07, 2023
Nanoparticles
Innovating Nanoparticles for Pharmaceutical Applications
DIANT Pharma
PAO-02-22-R250-18Feb 24, 2022